크레오에스지 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 큐로홀딩스, was filed 19 Jun 2026.
크레오에스지: what insiders have been doing
크레오에스지 belongs to the Health Care sector. Filings by its managers are published through DART (FSS). 5 insiders have disclosed 18 filings since 6 November 2025.
On the market, 2 insiders bought (3 purchases totalling €16k) while 4 insiders sold (10 sales totalling €73.7M). The amount is not disclosed for 11 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 1 major shareholder among the declarants. One trade stands out by size: a sale of €73.7M from 큐로홀딩스, disclosed on 23 April 2026.
The most recent open-market purchase was published on 19 June 2026, 144 days ago. The median gap between a trade and its publication by DART (FSS) is 7 days. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Compared with its exchange (2,657 companies, median 7 filings), a count of 18 filings is above the norm. Our records for 크레오에스지 go back to 2021, with 30 purchases and 13 sales on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -60.8%Entry ₩10,642 · Close at T+365 ₩4,172
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- ●Executives0DART
- 2,000 sharesKRXDART:20260619000452Canonical exit: 17 Sept 2026 (T+90)
- 18,810 sharesKRXDART:20260611000451Canonical exit: 9 Sept 2026 (T+90)
- 34,905,692 shares88.45% mcap100.0% of flowKRXDART:20260423000484
- 15,818,348 sharesShareKRXDART:20260423000507
- 7,905,675 sharesShareKRXDART:20260423000499
- 2,123,368 sharesShareKRXDART:20260423000511
- 86,293 shares@ ₩687.25130.019% mcap100.0% of flowShareKRXDART:20260421000268Canonical exit: 3 Dec 2024 (T+90)
- 0KRXDART:20260311003844
- 0KRXDART:20260303002315
- 500,000 sharesKRXDART:20260220001784
- 1,200,000 sharesKRXDART:20260205000381
- 0KRXDART:20260106000420
- 0KRXDART:20251218000376
- 45,339,614 sharesKRXDART:20251210000314
- 19,772,935 sharesShareKRXDART:20251210000318
25 of 79 declarations
About 크레오에스지
Creosg is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for patient well-being.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
